Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968707 · ClinicalTrials.gov registry record · Phase 3
In-vivo Efficacy Study of Patient Pre-operative Preps
A Phase 3 study, sponsored by Solventum US.
- Completed
- Registry status
- Phase 3
- Development phase
- 426
- Enrollment target
NCT01968707: Completed Phase 3 study, sponsored by Solventum US.
NCT01968707 is a Phase 3 study that has completed, run by Solventum US. The registered enrollment target is 426 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01968707, a Phase 3 study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 426 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
Primary Outcome
On the abdominal region a responder was a subject with a 2 log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline. On the inguinal region a responder was a subject with a 3 log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline.
Interventions
- DRUG Normal saline
- DRUG ChloraPrep Hi-Lite Orange
- DRUG 3M CHG/IPA Prep Tint 10.5-mL
- DRUG 3M CHG/IPA Prep Tint 26-mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
What the finished NCT01968707 record still lists
NCT01968707 is an interventional study that assigns participants to a tested intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 4 interventions - of which Normal saline is the first listed.
NCT01968707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01968707 about?
NCT01968707 is a clinical study titled "In-vivo Efficacy Study of Patient Pre-operative Preps". The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
What is the current status of trial NCT01968707?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 426 participants. The study started on 2013-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01968707?
The interventions under investigation include: Normal saline (DRUG), ChloraPrep Hi-Lite Orange (DRUG), 3M CHG/IPA Prep Tint 10.5-mL (DRUG), 3M CHG/IPA Prep Tint 26-mL (DRUG).
Who is sponsoring clinical trial NCT01968707?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01968707's enrollment target sits among peer trials
426 882nd of 2000 higher than 1,118 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790784 · 426 participants · Phase 3
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia